vs
Side-by-side financial comparison of MODIV INDUSTRIAL, INC. (MDV) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
MODIV INDUSTRIAL, INC. is the larger business by last-quarter revenue ($11.1M vs $8.6M, roughly 1.3× Sunshine Biopharma Inc.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -25.0%, a 35.9% gap on every dollar of revenue. On growth, MODIV INDUSTRIAL, INC. posted the faster year-over-year revenue change (-5.6% vs -10.6%). Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -3.8%).
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
MDV vs SBFM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.1M | $8.6M |
| Net Profit | $1.2M | $-2.1M |
| Gross Margin | — | 35.3% |
| Operating Margin | 45.8% | -20.9% |
| Net Margin | 11.0% | -25.0% |
| Revenue YoY | -5.6% | -10.6% |
| Net Profit YoY | -22.0% | 0.8% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.1M | $8.6M | ||
| Q3 25 | $11.7M | $9.4M | ||
| Q2 25 | $11.8M | $9.4M | ||
| Q1 25 | $11.8M | $8.9M | ||
| Q4 24 | $11.7M | $9.6M | ||
| Q3 24 | $11.7M | $8.4M | ||
| Q2 24 | $11.4M | $9.3M | ||
| Q1 24 | $12.0M | $7.5M |
| Q4 25 | $1.2M | $-2.1M | ||
| Q3 25 | $1.0M | $-883.8K | ||
| Q2 25 | $-2.0M | $-1.8M | ||
| Q1 25 | $829.0K | $-1.2M | ||
| Q4 24 | $1.6M | $-2.2M | ||
| Q3 24 | $-587.0K | $-1.2M | ||
| Q2 24 | $1.3M | $-494.3K | ||
| Q1 24 | $3.7M | $-1.3M |
| Q4 25 | — | 35.3% | ||
| Q3 25 | — | 32.6% | ||
| Q2 25 | — | 36.4% | ||
| Q1 25 | — | 30.7% | ||
| Q4 24 | — | 32.2% | ||
| Q3 24 | — | 34.0% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | — | 31.2% |
| Q4 25 | 45.8% | -20.9% | ||
| Q3 25 | 41.4% | -11.5% | ||
| Q2 25 | 9.8% | -21.8% | ||
| Q1 25 | 40.2% | -14.6% | ||
| Q4 24 | 45.4% | -21.7% | ||
| Q3 24 | 42.0% | -13.1% | ||
| Q2 24 | 44.6% | -13.6% | ||
| Q1 24 | 55.6% | -17.9% |
| Q4 25 | 11.0% | -25.0% | ||
| Q3 25 | 9.0% | -9.4% | ||
| Q2 25 | -17.1% | -18.8% | ||
| Q1 25 | 7.0% | -13.3% | ||
| Q4 24 | 13.3% | -22.5% | ||
| Q3 24 | -5.0% | -14.2% | ||
| Q2 24 | 11.6% | -5.3% | ||
| Q1 24 | 31.1% | -17.0% |
| Q4 25 | $0.02 | — | ||
| Q3 25 | $0.00 | $-0.54 | ||
| Q2 25 | $-0.32 | $-0.82 | ||
| Q1 25 | $-0.01 | $-0.44 | ||
| Q4 24 | $0.07 | $49.77 | ||
| Q3 24 | $-0.18 | $-11.61 | ||
| Q2 24 | $0.03 | $-43.48 | ||
| Q1 24 | $0.33 | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | — |
| Total DebtLower is stronger | $261.5M | — |
| Stockholders' EquityBook value | $162.7M | $23.0M |
| Total Assets | $476.5M | $30.1M |
| Debt / EquityLower = less leverage | 1.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | — | ||
| Q3 25 | $8.3M | — | ||
| Q2 25 | $5.8M | — | ||
| Q1 25 | $6.2M | — | ||
| Q4 24 | $11.5M | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $18.9M | — | ||
| Q1 24 | $18.4M | — |
| Q4 25 | $261.5M | — | ||
| Q3 25 | $279.7M | — | ||
| Q2 25 | $279.7M | — | ||
| Q1 25 | $279.7M | — | ||
| Q4 24 | $279.8M | — | ||
| Q3 24 | $279.7M | — | ||
| Q2 24 | $279.7M | — | ||
| Q1 24 | $279.6M | — |
| Q4 25 | $162.7M | $23.0M | ||
| Q3 25 | $164.8M | $24.2M | ||
| Q2 25 | $165.6M | $25.7M | ||
| Q1 25 | $171.1M | $22.7M | ||
| Q4 24 | $190.1M | $23.5M | ||
| Q3 24 | $186.3M | $25.0M | ||
| Q2 24 | $187.0M | $23.5M | ||
| Q1 24 | $188.0M | $24.8M |
| Q4 25 | $476.5M | $30.1M | ||
| Q3 25 | $499.6M | $31.5M | ||
| Q2 25 | $498.9M | $32.0M | ||
| Q1 25 | $506.8M | $29.2M | ||
| Q4 24 | $507.8M | $30.6M | ||
| Q3 24 | $507.4M | $30.1M | ||
| Q2 24 | $519.5M | $29.3M | ||
| Q1 24 | $522.5M | $31.9M |
| Q4 25 | 1.61× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 1.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.0M | $-1.6M |
| Free Cash FlowOCF − Capex | — | $-1.6M |
| FCF MarginFCF / Revenue | — | -18.9% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 12.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.0M | $-1.6M | ||
| Q3 25 | $4.1M | $-727.8K | ||
| Q2 25 | $3.9M | $-1.3M | ||
| Q1 25 | $3.0M | $-1.7M | ||
| Q4 24 | $18.2M | $-3.4M | ||
| Q3 24 | $5.1M | $-1.4M | ||
| Q2 24 | $4.7M | $-4.6M | ||
| Q1 24 | $3.0M | $-3.2M |
| Q4 25 | — | $-1.6M | ||
| Q3 25 | — | $-735.8K | ||
| Q2 25 | — | $-1.4M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $-3.5M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | -18.9% | ||
| Q3 25 | — | -7.8% | ||
| Q2 25 | — | -15.2% | ||
| Q1 25 | — | -19.3% | ||
| Q4 24 | — | -36.6% | ||
| Q3 24 | — | -22.2% | ||
| Q2 24 | — | -59.7% | ||
| Q1 24 | — | -43.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 6.1% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | 12.34× | — | ||
| Q3 25 | 3.95× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.68× | — | ||
| Q4 24 | 11.72× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.55× | — | ||
| Q1 24 | 0.80× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
